Taiwan · Delayed Price · Currency is TWD Hantech Bio-Technology Statistics
Total Valuation
TPEX:1294 has a market cap or net worth of TWD 2.02 billion. The enterprise value is 1.76 billion.
| Market Cap | 2.02B |
| Enterprise Value | 1.76B |
Important Dates
The next estimated earnings date is Thursday, August 20, 2026.
| Earnings Date | Aug 20, 2026 |
| Ex-Dividend Date | Jul 3, 2026 |
Share Statistics
TPEX:1294 has 36.33 million shares outstanding. The number of shares has increased by 1.32% in one year.
| Current Share Class | 36.33M |
| Shares Outstanding | 36.33M |
| Shares Change (YoY) | +1.32% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 28.80% |
| Owned by Institutions (%) | n/a |
| Float | 15.90M |
Valuation Ratios
The trailing PE ratio is 13.71.
| PE Ratio | 13.71 |
| Forward PE | n/a |
| PS Ratio | 2.34 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | 16.74 |
| P/OCF Ratio | 13.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.02, with an EV/FCF ratio of 14.56.
| EV / Earnings | 11.80 |
| EV / Sales | 2.04 |
| EV / EBITDA | 8.02 |
| EV / EBIT | 9.58 |
| EV / FCF | 14.56 |
Financial Position
The company has a current ratio of 2.00, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.00 |
| Quick Ratio | 1.63 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.49 |
| Debt / FCF | 0.89 |
| Interest Coverage | 70.08 |
Financial Efficiency
Return on equity (ROE) is 18.35% and return on invested capital (ROIC) is 24.82%.
| Return on Equity (ROE) | 18.35% |
| Return on Assets (ROA) | 9.45% |
| Return on Invested Capital (ROIC) | 24.82% |
| Return on Capital Employed (ROCE) | 20.18% |
| Weighted Average Cost of Capital (WACC) | 2.83% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 152 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 5.33 |
Taxes
In the past 12 months, TPEX:1294 has paid 36.53 million in taxes.
| Income Tax | 36.53M |
| Effective Tax Rate | 19.67% |
Stock Price Statistics
The stock price has decreased by -17.28% in the last 52 weeks. The beta is -0.25, so TPEX:1294's price volatility has been lower than the market average.
| Beta (5Y) | -0.25 |
| 52-Week Price Change | -17.28% |
| 50-Day Moving Average | 59.98 |
| 200-Day Moving Average | 64.23 |
| Relative Strength Index (RSI) | 40.46 |
| Average Volume (20 Days) | 20,903 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1294 had revenue of TWD 864.73 million and earned 149.13 million in profits. Earnings per share was 4.06.
| Revenue | 864.73M |
| Gross Profit | 310.04M |
| Operating Income | 183.76M |
| Pretax Income | 185.69M |
| Net Income | 149.13M |
| EBITDA | 212.68M |
| EBIT | 183.76M |
| Earnings Per Share (EPS) | 4.06 |
Balance Sheet
The company has 374.05 million in cash and 107.40 million in debt, with a net cash position of 266.65 million or 7.34 per share.
| Cash & Cash Equivalents | 374.05M |
| Total Debt | 107.40M |
| Net Cash | 266.65M |
| Net Cash Per Share | 7.34 |
| Equity (Book Value) | 822.29M |
| Book Value Per Share | 22.58 |
| Working Capital | 316.67M |
Cash Flow
In the last 12 months, operating cash flow was 152.30 million and capital expenditures -31.41 million, giving a free cash flow of 120.89 million.
| Operating Cash Flow | 152.30M |
| Capital Expenditures | -31.41M |
| Depreciation & Amortization | 28.92M |
| Net Borrowing | -50.29M |
| Free Cash Flow | 120.89M |
| FCF Per Share | 3.33 |
Margins
Gross margin is 35.85%, with operating and profit margins of 21.25% and 17.25%.
| Gross Margin | 35.85% |
| Operating Margin | 21.25% |
| Pretax Margin | 21.47% |
| Profit Margin | 17.25% |
| EBITDA Margin | 24.59% |
| EBIT Margin | 21.25% |
| FCF Margin | 13.98% |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 4.46%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 4.46% |
| Dividend Growth (YoY) | 26.61% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 58.63% |
| Buyback Yield | -1.32% |
| Shareholder Yield | 3.14% |
| Earnings Yield | 7.37% |
| FCF Yield | 5.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 3, 2026. It was a forward split with a ratio of 1.2.
| Last Split Date | Jul 3, 2026 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |